glp 1 for adolescents Use of GLP-1 weight-loss drugs soars among teens, young adults How young is too young

This pathological state is the upstream foundation for cardiovascular emergencies, diabetic microvascular complications, and a range of malignancies

Elbere I

Wegovy is approved for use in people 12 years and older and Zepbound is approved for use in adults

37 It may also correct metabolic imbalances, such as myo-inositol deficiency, which is linked to depression

Some are relying on legal interpretations involving research-use positioning or physician discretion

Providing access to safe, affordable weight loss solutions is more critical than ever yet many Americans do not have consistent access to these life-changing treatments